扫描下面的二维码:

二维码

"中文幻灯"标签列表

在非酒精性脂肪性肝炎中,PD-1/PD-L1可防止肝脏炎症和纤维化2009-05-03

ApoE和5-脂氧合酶双基因敲除鼠中肝巨噬细胞浸润以及胰岛素抵抗和TNF-α诱导的肝细胞损害减少2009-05-03

高脂诱导的NAFLD饮食模型中熊去氧胆酸溶血磷脂酰乙醇胺改善肝损伤和肝脂肪变2009-05-03

一项关于伴晚期纤维化的脂肪性肝炎兔模型研究2009-05-03

慢性HBV感染的治疗:关于临床实践中可达到的的新终点2009-05-03

Assessment of NAFLD2009-02-25

Acute Liver Failure2009-02-25

What are the risk factors & settings for NAFLD in China2009-02-25

Evolving Challenges in Hepatic Fibrosis2009-02-16

Strengthening Investigation on Insulin Resistance and Chronic Hepatitis C Virus Infection2009-02-14

New Insights into HBV Genotypes and HCC2009-02-14

Current Situation of the Epidemiology of HCC in Asia Pacific2009-02-14

The Advantages and Disadvantages of Non-invasive Assessment of Liver Fibrosis2009-02-13

Latest study on the Role of Quantitative HBsAg Measurement2009-02-13

Is Combination Treatment Superior to Monotherapy?2009-02-12

New Insights into Liver Transplantation for Hepatocellular Carcinoma2009-02-12

HBV Providers' Choice in Prime Time2009-02-09

Clinical managment of hepatitis C in an environment with limited acces to treatment2009-02-05

e抗原阳性的慢乙肝:为什么应用核苷类药物2009-02-04

COMMENT JE TRAITE HVC AVEC LES MEDICAMENTS DISPONIBLES DANS MON PAYS2009-02-04

推荐标签 更多 >>

栏目标签

领域标签



设为首页 | 加入收藏 | 网站地图 | 订阅杂志 | 关于我们 | 版权声明 | 联系方式|招贤纳士
国际肝病  版权所有  京ICP备15060708号   (京)-非经营性-2016-0001京公网安备 11010502033341号 2004-2020  www.ihepa.com  ALL Rights  Reserved

增值电信业务经营许可证:京B2-20212326

网站统计